The health ministry has ordered AstraZeneca K.K., the importer of the controversial lung cancer drug Iressa, to include a patient form with the medicine clearly stating the possibility of fatal side effects, ministry sources said Tuesday.
It is the first time the ministry has ordered a drug firm to make explicit the possibility that a drug may have life-threatening effects in a patient form.
It is also extremely rare for the government to order a drug firm to directly inform patients about side effects. Pharmaceutical firms have usually been told to provide such information to doctors.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.